Guardant CTO exercises RSUs, pays taxes in stock
Guardant Health Chief Technology Officer Darya Chudova reported routine equity compensation activity tied to vesting restricted stock units.
Rhea-AI Filing Summary
Guardant Health Chief Technology Officer Darya Chudova reported routine equity compensation activity tied to vesting restricted stock units. On April 1, 2026, she acquired a total of 13,029 shares of Guardant Health common stock through the exercise and conversion of multiple restricted stock unit awards at a stated price of $0.00 per share.
To cover tax withholding obligations upon vesting, 7,005 shares were retained by the company at a price of $91.15 per share, as described in the footnotes. After these compensation-related transactions and tax withholding, Chudova directly holds 70,376 shares of Guardant Health common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,339 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 3,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 6,699 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,339 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,324 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,699 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 7,005 | $91.15 | $639K |
Footnotes (6)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F5. This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F6. This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Key Figures
Key Terms
Restricted Stock Units financial
tax withholding obligations financial
vests in equal quarterly installments financial
derivative exercise/conversion financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Guardant Health (GH) CTO Darya Chudova report?
Were the Guardant Health (GH) CTO’s transactions open-market buys or sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.